ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 79 filers reported holding ANTARES PHARMA INC in Q3 2014. The put-call ratio across all filers is 37.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $365,000 | -41.2% | 112,768 | -41.5% | 0.65% | -35.3% |
| Q2 2017 | $621,000 | +220.1% | 192,734 | +181.8% | 1.00% | +260.3% |
| Q1 2017 | $194,000 | +120.5% | 68,386 | +80.8% | 0.28% | +89.7% |
| Q4 2016 | $88,000 | +252.0% | 37,826 | +159.2% | 0.15% | +231.8% |
| Q3 2016 | $25,000 | +25.0% | 14,594 | -24.9% | 0.04% | +37.5% |
| Q2 2016 | $20,000 | +11.1% | 19,421 | +177.4% | 0.03% | +52.4% |
| Q4 2014 | $18,000 | +38.5% | 7,000 | 0.0% | 0.02% | +23.5% |
| Q3 2014 | $13,000 | -86.6% | 7,000 | -80.8% | 0.02% | -87.9% |
| Q2 2014 | $97,000 | -24.2% | 36,500 | 0.0% | 0.14% | -34.3% |
| Q1 2014 | $128,000 | -21.5% | 36,500 | 0.0% | 0.21% | -13.4% |
| Q4 2013 | $163,000 | – | 36,500 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |